A carregar cotações...
Previsão
Não temos dados de analistas para esta empresa.
Notícias Ir para o feed de notícias
DocCheck reports preliminary 2025 results: revenue and EBIT rise
DocCheck expects 2025 revenue of between €55.1 million and €55.4 million (previous year: €53.8 million) and EBIT of €7.8 million to €8.1 million (previous year: €6.6 million), putting EBIT above the most recently adjusted forecast. The cause is a better-than-expected business performance in the fourth quarter of 2025. Cash and cash equivalents fell to €14.5 million (previous year: €17.0 million); earnings per share cannot yet be quantified. For 2026 the company expects organic growth in an economically challenging environment. » Mais em finanzen.net
DocCheck reports preliminary nine-month figures: revenue and EBIT increased
The DocCheck Group generated revenue of €39.7 million in the first nine months of 2025 (previous year: €37.5 million) and an EBIT of €5.5–5.8 million (previous year: €3.5 million). The revenue forecast for 2025 remains €50.0–55.0 million, while the earnings forecast was raised from €5.0–5.5 million to €6.5–6.8 million. Liquid funds amounted to €14.9 million at the reporting date (previous year: €15.8 million); statements on earnings per share are not yet possible. » Mais em finanzen.net
Dividendos históricos Dividendos
Todos os indicadores de dividendos Todos os indicadoresDados financeiros da empresa
| (EUR) | dezembro de 2025 | |
|---|---|---|
| Receitas | 28,77 mi | - |
| Ganho bruto | 6,39 mi | - |
| Ganho líquido | 2,88 mi | - |
| EBITDA | 5,9 mi | - |
Dados fundamentais
| Métrica | Valor |
|---|---|
Capitalização bolsista | € 55,81 mi |
Número de ações | 5,07 mi |
Máximo/mínimo de 52 semanas | € 15,90 - € 10,60 |
Rentabilidade de dividendos | 9,01% |
Dividendos TTM | € 1,00 |
Beta | 0,90 |
PER (PE Ratio) | 10,48 |
PEG (PEG Ratio) | 10,90 |
P/VC (PB Ratio) | 1,34 |
P/V (PS Ratio) | 1,00 |
Perfil da empresa
Die DocCheck AG bietet Marketing-, Customer Relationship Management- und E-Commerce-Dienstleistungen für den Gesundheitssektor in Europa an. Das Unternehmen betreibt das DocCheck-Portal für den Informationsaustausch im Internet sowie Online- und E-Commerce-Services für Akteure im Gesundheitsmarkt. Darüber hinaus entwickelt und implementiert es Kommunikationsstrategien für neue und traditionelle Medien im Gesundheitswesen und Business-to-Business-Sektor und fördert Startups im Gesundheitswesen durch Seed-Finanzierung. Die DocCheck AG hat ihren Sitz in Köln, Deutschland.
| Nome | DocCheck |
| CEO | Frank Nicolas Antwerpes |
| Sede | Cologne,
nw Alemanha |
| Site | |
| Setor | Tecnologias da informação |
| Indústria | Serviços de TI |
| Entrada em bolsa | 17/04/2020 |
| Colaboradores | 414 |
Símbolos de ticker
| Bolsa | Símbolo |
|---|---|
XETRA | AJ91.DE |
Frankfurt | AJ91.F |
Düsseldorf | AJ91.DU |
SIX | AJ91.SW |
München | AJ91.MU |
